ReGen III Announces Executive Changes
ReGen III Corp. (TSXV: GIII) (OTCQB: ISRJF) (FSE: PN4) has announced executive changes effective immediately. Greg Clarkes has stepped down as CEO for personal reasons but will continue as Chairman of the Board. Mark Redcliffe, previously the President, has been appointed as the new CEO and President.
Clarkes founded ReGen III in 2017, securing patents and shifting the company's focus to high-value re-refining. He played a important role in obtaining FEL2 financing and negotiating a multi-year offtake agreement with bp Products North America. Under his leadership, the company developed its proprietary ReGen™ process, protected by 32 pending or awarded patents.
Redcliffe, who joined the company in 2018, has been instrumental in key successes including feedstock and offtake agreements, product certifications, and financial partnerships. The Board expressed confidence in Redcliffe's ability to lead the company and advance ongoing negotiations.
ReGen III Corp. (TSXV: GIII) (OTCQB: ISRJF) (FSE: PN4) ha annunciato cambiamenti esecutivi con effetto immediato. Greg Clarkes ha lasciato la carica di CEO per motivi personali, ma continuerà come Presidente del Consiglio. Mark Redcliffe, precedentemente Presidente, è stato nominato nuovo CEO e Presidente.
Clarkes ha fondato ReGen III nel 2017, ottenendo brevetti e orientando l'azienda verso il riraffinamento di alto valore. Ha svolto un ruolo importante nell'ottenimento del finanziamento FEL2 e nella negoziazione di un contratto pluriennale di approvvigionamento con bp Products North America. Sotto la sua guida, l'azienda ha sviluppato il proprio processo proprietario ReGen™, protetto da 32 brevetti in attesa o concessi.
Redcliffe, che ha aderito all'azienda nel 2018, è stato fondamentale per i successi chiave, inclusi accordi di approvvigionamento e di vendita, certificazioni di prodotto e partnership finanziarie. Il Consiglio ha espresso fiducia nelle capacità di Redcliffe di guidare l'azienda e di portare avanti le negoziazioni in corso.
ReGen III Corp. (TSXV: GIII) (OTCQB: ISRJF) (FSE: PN4) ha anunciado cambios ejecutivos con efecto inmediato. Greg Clarkes ha renunciado como CEO por motivos personales, pero continuará como Presidente de la Junta. Mark Redcliffe, anteriormente Presidente, ha sido designado como el nuevo CEO y Presidente.
Clarkes fundó ReGen III en 2017, asegurando patentes y cambiando el enfoque de la empresa hacia el refinamiento de alto valor. Desempeñó un papel importante en la obtención de financiamiento FEL2 y en la negociación de un contrato de suministro a largo plazo con bp Products North America. Bajo su liderazgo, la compañía desarrolló su proceso propietario ReGen™, protegido por 32 patentes pendientes o concedidas.
Redcliffe, quien se unió a la empresa en 2018, ha sido instrumental en los éxitos clave, incluidos acuerdos de materia prima y de suministro, certificaciones de productos y asociaciones financieras. La Junta expresó confianza en la capacidad de Redcliffe para liderar la empresa y avanzar en las negociaciones en curso.
ReGen III Corp. (TSXV: GIII) (OTCQB: ISRJF) (FSE: PN4)는 즉각 발효되는 임원 변경을 발표했습니다. Greg Clarkes는 개인적인 이유로 CEO직을 사임했지만 이사회 의장으로 계속 활동할 것입니다. Mark Redcliffe는 이전의 사장에서 새로운 CEO이자 사장으로 임명되었습니다.
Clarkes는 2017년에 ReGen III를 설립하고 특허를 확보하여 회사의 초점을 고부가가치 재정제조로 전환했습니다. 그는 FEL2 자금을 확보하고 bp Products North America와 다년간의 공급 계약을 협상하는 데 중요한 역할을 했습니다. 그의 지도 아래, 회사는 32건의 특허가 출원 중이거나 승인된 자체 ReGen™ 프로세스를 개발했습니다.
2018년에 회사에 합류한 Redcliffe는 원료 및 공급 계약, 제품 인증 및 재무 파트너십을 포함한 주요 성공에 중요한 역할을 했습니다. 이사회는 Redcliffe가 회사를 이끌고 진행 중인 협상을 발전시킬 수 있는 능력에 대한 확신을 표명했습니다.
ReGen III Corp. (TSXV: GIII) (OTCQB: ISRJF) (FSE: PN4) a annoncé des changements exécutifs avec effet immédiat. Greg Clarkes a démissionné de son poste de PDG pour des raisons personnelles, mais continuera en tant que Président du Conseil. Mark Redcliffe, précédemment Président, a été nommé nouveau PDG et Président.
Clarkes a fondé ReGen III en 2017, sécurisant des brevets et réorientant l'entreprise vers le raffinage à forte valeur ajoutée. Il a joué un rôle important dans l'obtention d'un financement FEL2 et la négociation d'un contrat d'approvisionnement pluriannuel avec bp Products North America. Sous sa direction, l'entreprise a développé son processus propriétaire ReGen™, protégé par 32 brevets en instance ou accordés.
Redcliffe, qui a rejoint l'entreprise en 2018, a été déterminant dans des succès clés, y compris les accords de matières premières et d'approvisionnement, les certifications de produits et les partenariats financiers. Le Conseil a exprimé sa confiance dans la capacité de Redcliffe à diriger l'entreprise et à faire avancer les négociations en cours.
ReGen III Corp. (TSXV: GIII) (OTCQB: ISRJF) (FSE: PN4) hat Änderungen in der Geschäftsführung mit sofortiger Wirkung bekannt gegeben. Greg Clarkes ist als CEO zurückgetreten aus persönlichen Gründen, wird jedoch weiterhin als Vorsitzender des Boards tätig sein. Mark Redcliffe, zuvor Präsident, wurde als neuer CEO und Präsident ernannt.
Clarkes gründete ReGen III im Jahr 2017, sicherte Patente und verlagerte den Fokus des Unternehmens auf die hochpreisige Rückverarbeitung. Er spielte eine wichtige Rolle bei der Beschaffung von FEL2-Finanzierung und der Aushandlung eines mehrjährigen Liefervertrags mit bp Products North America. Unter seiner Führung entwickelte das Unternehmen seinen proprietären ReGen™-Prozess, der durch 32 ausstehende oder erteilte Patente geschützt ist.
Redcliffe, der 2018 zum Unternehmen kam, war maßgeblich an Schlüssel-Erfolgen beteiligt, darunter Vereinbarungen über Rohstoffe und Abnahme, Produktzertifizierungen und Finanzpartnerschaften. Der Vorstand äußerte Vertrauen in Redcliffes Fähigkeit, das Unternehmen zu führen und laufende Verhandlungen voranzutreiben.
- Mark Redcliffe, with extensive experience in the company, appointed as new CEO and President
- Greg Clarkes to continue providing leadership as Chairman of the Board
- Company has 32 pending or awarded patents protecting its proprietary ReGen™ process
- Existing multi-year offtake agreement with bp Products North America
- Unexpected departure of founding CEO Greg Clarkes for personal reasons
Vancouver, British Columbia--(Newsfile Corp. - September 23, 2024) - ReGen III Corp. (TSXV: GIII) (OTCQB: ISRJF) (FSE: PN4) ("ReGen III" or the "Company"), a leading clean technology company commercializing the patented ReGen™ process to upcycle used motor oil ("UMO") into high-value Group III base oils, announces today that effective immediately Greg Clarkes, CEO and Chairman of the Board, has stepped down from his role as CEO for personal reasons. Mr. Clarkes will continue to serve as Chairman of the Board, providing ongoing leadership and guidance to the Company.
Mr. Clarkes founded ReGen III in 2017, securing the underlying process patent suite and re-capitalizing the firm's strategic shift to high-value re-refining. Amongst other corporate milestones, Mr. Clarkes was integral to securing FEL2 financing and negotiating the Company's multi-year offtake agreement with bp Products North America. Mr. Clarkes was also a strong supporter of building out the Company's intellectual property, wherein the Company has validated, de-risked and protected its proprietary ReGen™ process through numerous technical studies and 32 pending or awarded patents.
Effective immediately, Mark Redcliffe, President of ReGen III, will assume the roles of CEO and President.
Mr. Clarkes expressed his confidence in Mr. Redcliffe's ability to lead the organization. "Mark's strategic mindset and intimate understanding of our business make him a natural choice to step into the role of CEO," said Mr. Clarkes. "Since joining the Company in 2018, Mark has been a driving force for ReGen III, instrumental in our key successes including those surrounding feedstock and offtake, product certifications, financial partnerships and equity investments. Mark has worked closely with me to advance offtake negotiations, and I am confident he will be able to lead these negotiations to a successful close in due course. The Board and I are also confident that Mark will guide the Company with the same excellence and dedication he has shown throughout the years."
"I am honored to step into the role of CEO and am committed to seeing our innovative, sustainable ReGen™ process make a positive impact in the market. I'd also like to express my sincere appreciation to Greg for his mentorship and extensive contributions to advancing our technology and project over the years. The team and I look forward to continuing to work with Greg, in his role as Chairman, to deliver on key milestones," said Mr. Redcliffe.
The Board of Directors would like to extend its gratitude to Mr. Clarkes for his passion and dedicated service as CEO and looks forward to his continued contributions as Chairman.
About ReGen III
ReGen III is a cleantech company commercializing its patented ReGen™ technology to upcycle UMO into high-value Group III base oils. With a focus on creating sustainable solutions that generate better environmental outcomes and compelling economics, the Company's ReGen™ process is expected to reduce CO2e emissions by
In 2022, ReGen III completed FEL2 and value engineering for the Company's 5,600 bpd UMO Texas recycling facility, with the support of world-class engineering, construction and licensed vendor teams - including Koch Project Solutions, LLC, PCL Industrial Management Ltd., Studi Tecnologie Progetti S.p.A., Koch Modular Process Systems and Duke Technologies.
Operating in an underserved segment of the base oil market, ReGen III aims to become the world's largest producer of sustainable Group III base oil.
For more information on ReGen III or to subscribe to the Company's mailing list, please visit: www.regeniii.com/investors/corporate-presentations and www.regeniii.com/newsletter-subscription.
For further information, please contact:
Investor & Media inquiries:
Email: investors@regeniii.com
Corporate Inquiries:
Kimberly Hedlin
Vice President, Corporate Finance
Tel: (403) 921-9012
Email: info@regeniii.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Certain information other than statements of historical facts contained in this news release constitutes "forward-looking information" or "forward-looking statements" (collectively, "forward-looking information"). Without limiting the foregoing, such forward-looking information includes statements regarding the Company's business plans, expectations, capital costs and objectives. In this news release, words such as "may", "would", "could", "will", "likely", "believe", "expect", "anticipate", "intend", "plan", "estimate" and similar words and the negative form thereof are used to identify forward-looking information. Forward-looking information should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether, or the times at or by which, such future performance will be achieved. Forward-looking information is based on information available at the time and/or the Company management's good faith belief with respect to future events and is subject to known or unknown risks, uncertainties, assumptions and other unpredictable factors, many of which are beyond the Company's control. For additional information with respect to these and other factors and assumptions underlying the forward-looking information made in this news release, see the Company's most recent Management's Discussion and Analysis and financial statements and other documents filed by the Company with the Canadian securities commissions and the discussion of risk factors set out therein. Such documents are available at www.sedarplus.ca under the Company's profile and on the Company's website, www.ReGenIII.com. The forward-looking information set forth herein reflects the Company's expectations as at the date of this news release and is subject to change after such date. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/224160
FAQ
What executive changes were announced by ReGen III Corp. (OTCQB: ISRJF)?
Who is the new CEO of ReGen III Corp. (OTCQB: ISRJF)?
What is ReGen III Corp.'s (OTCQB: ISRJF) main business focus?
How many patents does ReGen III Corp. (OTCQB: ISRJF) have for its ReGen™ process?
